Abstract
Healing fractures resulting from bone disorders such as osteoporosis, osteoarthritis, osteomyelitis, and osteosarcoma remain a significant clinical challenge. In this chapter, we focus on scaffold based local drug delivery applications for promoting bone regeneration. For this purpose, we first review bone disorders, which require drug treatment and current fabrication techniques for bone tissue scaffold as a drug carrier. Next, we address the role of antimicrobial agents, anti-inflammatory drugs, anti-cancer drugs and bisphosphonates in promoting vascularized bone regeneration and discuss various local therapeutic delivery strategies for controlled and sustained drug delivery. Specifically, this review addresses the concept of drug loaded scaffold design and local drug release effects on bone regeneration. We conclude this review with a discussion of local drug delivery approaches to bone regeneration and discuss why it has the potential to be more efficient than traditional bone treatment methods.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andronescu E, Ficai A, Albu MG, Mitran V, Sonmez M, Ficai D, Ion R, Cimpean A (2013) Collagen-hydroxyapatite/cisplatin drug delivery systems for locoregional treatment of bone cancer. Technol Cancer Res Treat 12(4):275–284
Anselme K (2000) Osteoblast adhesion on biomaterials. Biomaterials 21(7):667–681
Aydemir Sezer U, Arslantunali D, Aksoy EA, Hasirci V, Hasirci N (2014) Poly (ε-caprolactone) composite scaffolds loaded with gentamicin-containing β-tricalcium phosphate/gelatin microspheres for bone tissue engineering applications. J Appl Polym Sci 131(8)
Babaie E, Lin B, Bhaduri SB (2017) A new method to produce macroporous Mg-phosphate bone growth substitutes. Mater Sci Eng C 75:602–609
Baron R, Hesse E (2012) Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metabol 97(2):311–325
Barrère F, van Blitterswijk CA, de Groot K (2006) Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomedicine 1(3):317–332
Bennet D, Marimuthu M, Kim S, An J (2012) Dual drug-loaded nanoparticles on self-integrated scaffold for controlled delivery. Int J Nanomedicine 7:3399
Bhattacharyya S, Nair LS, Singh A, Krogman NR, Greish YE, Brown PW, Allcock HR, Laurencin CT (2006) Electrospinning of poly [bis (ethyl alanato) phosphazene] nanofibers. J Biomed Nanotechnol 2(1):36–45
Bhattacharyya S, Kumbar SG, Khan YM, Nair LS, Singh A, Krogman NR, Brown PW, Allcock HR, Laurencin CT (2009) Biodegradable polyphosphazene-nanohydroxyapatite composite nanofibers: scaffolds for bone tissue engineering. J Biomed Nanotechnol 5(1):69–75
Bhattarai N, Gunn J, Zhang M (2010) Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 62(1):83–99
Bignon A, Chouteau J, Chevalier J, Fantozzi G, Carret J-P, Chavassieux P, Boivin G, Melin M, Hartmann D (2003) Effect of micro-and macroporosity of bone substitutes on their mechanical properties and cellular response. J Mater Sci Mater Med 14(12):1089–1097
Bijlsma JW, Berenbaum F, Lafeber FP (2011) Osteoarthritis: an update with relevance for clinical practice. Lancet 377(9783):2115–2126
Çalamak S, Erdoğdu C, Özalp M, Ulubayram K (2014) Silk fibroin based antibacterial bionanotextiles as wound dressing materials. Mater Sci Eng C 43:11–20
Calamak S, Aksoy EA, Erdogdu C, Sagıroglu M, Ulubayram K (2015) Silver nanoparticle containing silk fibroin bionanotextiles. J Nanopart Res 17(2):87
Calamak S, Aksoy EA, Ertas N, Erdogdu C, Sagıroglu M, Ulubayram M (2015) Ag/silk fibroin nanofibers: effect of fibroin morphology on Ag+ release and antibacterial activity. Eur Polym J 67:99–112
Calamak S, Shahbazi R, Eroglu I, Gultekinoglu M, Ulubayram K (2017) An overview of nanofiber-based antibacterial drug design. Expert Opin Drug Discovery 12:391–406
Cancedda R (2009) Cartilage and bone extracellular matrix. Curr Pharm Des 15(12):1334–1348
Chapurlat R, Delmas P (2004) New treatments in osteoporosis. Revue Med Interne 25:S573–S579
Chen Y, Kawazoe N, Chen G (2017) Preparation of dexamethasone-loaded biphasic calcium phosphate nanoparticles/collagen porous composite scaffolds for bone tissue engineering. Acta Biomater 67:341–353
Cheng T, Qu H, Zhang G, Zhang X (2017) Osteogenic and antibacterial properties of vancomycin-laden mesoporous bioglass/PLGA composite scaffolds for bone regeneration in infected bone defects. Artif Cells Nanomed Biotechnol:1–13
Cicuéndez M, Doadrio JC, Hernández A, Portolés MT, Izquierdo-Barba I, Vallet-Regà M (2018) Multifunctional pH sensitive 3D scaffolds for treatment and prevention of bone infection. Acta Biomater 65:450–461
Cooke MN, Fisher JP, Dean D, Rimnac C, Mikos AG (2003) Use of stereolithography to manufacture critical-sized 3D biodegradable scaffolds for bone ingrowth. J Biomed Mater Res B Appl Biomater 64(2):65–69
Cutolo M, Berenbaum F, Hochberg M, Punzi L, Reginster J-Y (2015) Commentary on recent therapeutic guidelines for osteoarthritis. Semin Arthritis Rheum 44(6):611–617 Elsevier
Decambron A, Manassero M, Bensidhoum M, Lecuelle B, Logeart-Avramoglou D, Petite H, Viateau V (2017) A comparative study of tissue-engineered constructs from Acropora and Porites coral in a large animal bone defect model. Bone Joint Res 6(4):208–215
Denry I, Holloway JA (2014) Low temperature sintering of fluorapatite glass-ceramics. Dent Mater 30(2):112–121
Denry I, Goudouri OM, Harless J, Holloway JA (2018) Rapid vacuum sintering: a novel technique for fabricating fluorapatite ceramic scaffolds for bone tissue engineering. J Biomed Mater Res B Appl Biomater 106(1):291–299
Devin JE, Attawia MA, Laurencin CT (1996) Three-dimensional degradable porous polymer-ceramic matrices for use in bone repair. J Biomater Sci Polym Ed 7(8):661–669
Downey PA, Siegel MI (2006) Bone biology and the clinical implications for osteoporosis. Phys Ther 86(1):77–91
Durucan C, Brown PW (2000) Calcium-deficient hydroxyapatite-PLGA composites: mechanical and microstructural investigation. J Biomed Mater Res A 51(4):726–734
Ezra A, Golomb G (2000) Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev 42(3):175–195
Farooq A, Yar M, Khan AS, Shahzadi L, Siddiqi SA, Mahmood N, Rauf A, Manzoor F, Chaudhry AA, ur Rehman I (2015) Synthesis of piroxicam loaded novel electrospun biodegradable nanocomposite scaffolds for periodontal regeneration. Mater Sci Eng C 56:104–113
Feng X, McDonald JM (2011) Disorders of bone remodeling. Annu Rev Pathol Mech Dis 6:121–145
Fischer P, Romano V, Weber H-P, Karapatis N, Boillat E, Glardon R (2003) Sintering of commercially pure titanium powder with a Nd: YAG laser source. Acta Mater 51(6):1651–1662
Florencio-Silva R, Sasso GR d S, Sasso-Cerri E, Simões MJ, Cerri PS (2015) Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int 2015:421746
Fu Q, Saiz E, Rahaman MN, Tomsia AP (2011) Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives. Mater Sci Eng C 31(7):1245–1256
Gitelis S, Brebach GT (2002) The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg 10(1):53–60
Glyn-Jones S, Palmer A, Price A, Vincent T, Weinans H, Carr AJ (2015) Osteoarthritis. Lancet 386(9991):376–387
Govender T, Stolnik S, Garnett MC, Illum L, Davis SS (1999) PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 57(2):171–185
Gu W, Wu C, Chen J, Xiao Y (2013) Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. Int J Nanomedicine 8:2305
Guo J, Zhang Q, Li J, Liu Y, Hou Z, Chen W, Jin L, Tian Y, Ju L, Liu B (2017) Local application of an ibandronate/collagen sponge improves femoral fracture healing in ovariectomized rats. PLoS One 12(11):e0187683
Hamadouche M, Sedel L (2000) Ceramics in orthopaedics. Bone Joint J 82(8):1095–1099
Hatzenbuehler J, Pulling TJ (2011) Diagnosis and management of osteomyelitis. Am Fam Physician 84(9):1027–1033
Heino TJ, Hentunen TA, Väänänen HK (2004) Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Exp Cell Res 294(2):458–468
Henderson PW, Singh SP, Krijgh DD, Yamamoto M, Rafii DC, Sung JJ, Rafii S, Rabbany SY, Spector JA (2011) Stromal-derived factor-1 delivered via hydrogel drug-delivery vehicle accelerates wound healing in vivo. Wound Repair Regen 19(3):420–425
Hess U, Shahabi S, Treccani L, Streckbein P, Heiss C, Rezwan K (2017) Co-delivery of cisplatin and doxorubicin from calcium phosphate beads/matrix scaffolds for osteosarcoma therapy. Mater Sci Eng C 77:427–435
Hirabayashi H, Fujisaki J (2003) Bone-specific drug delivery systems. Clin Pharmacokinet 42(15):1319–1330
Holzwarth JM, Ma PX (2011) Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials 32(36):9622–9629
Iacono MV (2007) Osteoporosis: a national public health priority. J Perianesth Nurs 22(3):175–183
Iannazzo D, Pistone A, Espro C, Galvagno S (2015) Drug delivery strategies for bone tissue regeneration. In: Panseri S, Taraballi F, Cunha C (eds) Biomimetic approaches for tissue healing. OMICS International, Foster City, pp 1–39
Inzana JA, Trombetta RP, Schwarz EM, Kates SL, Awad HA (2015) 3D printed bioceramics for dual antibiotic delivery to treat implant-associated bone infection. Eur Cell Mater 30:232–247
Iseme RA, Mcevoy M, Kelly B, Agnew L, Walker FR, Attia J (2017) Is osteoporosis an autoimmune mediated disorder? Bone Rep 7:121–131
Jiang S, Zhang Y, Shu Y, Wu Z, Cao W, Huang W (2017) Amino-functionalized mesoporous bioactive glass for drug delivery. Biomed Mater 12(2):025017
Jo YS, Rizzi SC, Ehrbar M, Weber FE, Hubbell JA, Lutolf MP (2010) Biomimetic PEG hydrogels crosslinked with minimal plasmin-sensitive tri-amino acid peptides. J Biomed Mater Res A 93(3):870–877
Kim H-W, Knowles JC, Kim H-E (2004) Hydroxyapatite/poly (ε-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 25(7–8):1279–1287
Kim HW, Knowles JC, Kim HE (2004) Development of hydroxyapatite bone scaffold for controlled drug release via poly (ε-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res B Appl Biomater 70(2):240–249
Kim H-W, Knowles JC, Kim H-E (2005) Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release. J Mater Sci Mater Med 16(3):189–195
Kim K, Yeatts A, Dean D, Fisher JP (2010) Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression. Tissue Eng Part B Rev 16(5):523–539
Kini U, Nandeesh B (2012) Physiology of bone formation, remodeling, and metabolism. In: Radionuclide and hybrid bone imaging. Springer, Berlin, pp 29–57
Kokubo T, Ito S, Huang Z, Hayashi T, Sakka S, Kitsugi T, Yamamuro T (1990) Ca, P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res A 24(3):331–343
Kothapalli C, Wei M, Vasiliev A, Shaw M (2004) Influence of temperature and concentration on the sintering behavior and mechanical properties of hydroxyapatite. Acta Mater 52(19):5655–5663
Kundu B, Soundrapandian C, Nandi SK, Mukherjee P, Dandapat N, Roy S, Datta BK, Mandal TK, Basu D, Bhattacharya RN (2010) Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial. Pharm Res 27(8):1659–1676
Langton C, Whitehead M, Langton D, Langley G (1997) Development of a cancellous bone structural model by stereolithography for ultrasound characterisation of the calcaneus. Med Eng Phys 19(7):599–604
Lasprilla AJ, Martinez GA, Lunelli BH, Jardini AL, Maciel Filho R (2012) Poly-lactic acid synthesis for application in biomedical devices—a review. Biotechnol Adv 30(1):321–328
Lew DP, Waldvogel FA (2004) Osteomyelitis. Lancet 364(9431):369–379
Liao S, Cui F, Zhang W, Feng Q (2004) Hierarchically biomimetic bone scaffold materials: nano-HA/collagen/PLA composite. J Biomed Mater Res B Appl Biomater 69(2):158–165
Lienemann PS, Karlsson M, Sala A, Wischhusen HM, Weber FE, Zimmermann R, Weber W, Lutolf MP, Ehrbar M (2013) A versatile approach to engineering biomolecule-presenting cellular microenvironments. Adv Healthc Mater 2(2):292–296
Lima ALL, Oliveira PR, Carvalho VC, Cimerman S, Savio E (2014) Recommendations for the treatment of osteomyelitis. Braz J Infect Dis 18(5):526–534
Lin C-C, Fu S-J, Lin Y-C, Yang I-K, Gu Y (2014) Chitosan-coated electrospun PLA fibers for rapid mineralization of calcium phosphate. Int J Biol Macromol 68:39–47
Locs J, Li W, Sokolova M, Roether JA, Loca D, Boccaccini AR (2015) Zoledronic acid impregnated and poly (L-lactic acid) coated 45S5 Bioglass®-based scaffolds. Mater Lett 156:180–182
Long M, Rack H (1998) Titanium alloys in total joint replacement—a materials science perspective. Biomaterials 19(18):1621–1639
Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G (2006) Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 32(6):423–436
Luetke A, Meyers PA, Lewis I, Juergens H (2014) Osteosarcoma treatment–where do we stand? A state of the art review. Cancer Treat Rev 40(4):523–532
McLaren JS, White L, Cox H, Ashraf W, Rahman C, Blunn G, Goodship A, Quirk R, Shakesheff KM, Bayston R (2014) A biodegradable antibiotic-impregnated scaffold to prevent osteomyelitis in a contaminated in vivo bone defect model. Eur Cell Mater 27:332–349
Meng Z, Zheng W, Li L, Zheng Y (2011) Fabrication, characterization and in vitro drug release behavior of electrospun PLGA/chitosan nanofibrous scaffold. Mater Chem Phys 125(3):606–611
Mi H-Y, Salick MR, Jing X, Jacques BR, Crone WC, Peng X-F, Turng L-S (2013) Characterization of thermoplastic polyurethane/polylactic acid (TPU/PLA) tissue engineering scaffolds fabricated by microcellular injection molding. Mater Sci Eng C 33(8):4767–4776
Mitra D, Whitehead J, Yasui OW, Leach JK (2017) Bioreactor culture duration of engineered constructs influences bone formation by mesenchymal stem cells. Biomaterials 146:29–39
Mouriño V, Boccaccini AR (2009) Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface: rsif20090379
Ngiam M, Liao S, Patil AJ, Cheng Z, Chan CK, Ramakrishna S (2009) The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering. Bone 45(1):4–16
Nguyen BNB, Moriarty RA, Kamalitdinov T, Etheridge JM, Fisher JP (2017) Collagen hydrogel scaffold promotes mesenchymal stem cell and endothelial cell coculture for bone tissue engineering. J Biomed Mater Res A 105(4):1123–1131
Niinomi M (2003) Recent research and development in titanium alloys for biomedical applications and healthcare goods. Sci Technol Adv Mater 4(5):445–454
Oonishi H, Kushitani S, Yasukawa E, Iwaki H, Hench LL, Wilson J, Tsuji E, Sugihara T (1997) Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop Relat Res 334:316–325
Pehlivan SB, Yavuz B, Çalamak S, Ulubayram K, Kaffashi A, Vural I, Çakmak HB, Durgun ME, Denkbaş EB, Ünlü N (2015) Preparation and in vitro/in vivo evaluation of cyclosporin a-loaded nanodecorated ocular implants for subconjunctival application. J Pharm Sci 104(5):1709–1720
Peter M, Binulal N, Nair S, Selvamurugan N, Tamura H, Jayakumar R (2010) Novel biodegradable chitosan–gelatin/nano-bioactive glass ceramic composite scaffolds for alveolar bone tissue engineering. Chem Eng J 158(2):353–361
Petite H, Viateau V, Bensaid W, Meunier A, de Pollak C, Bourguignon M, Oudina K, Sedel L, Guillemin G (2000) Tissue-engineered bone regeneration. Nat Biotechnol 18(9):959–963
Pirhonen E, Moimas L, Haapanen J (2003) Porous bioactive 3-D glass fiber scaffolds for tissue engineering applications manufactured by sintering technique. Key Eng Mater 240–242: 237–240. Trans Tech Publications
Place ES, George JH, Williams CK, Stevens MM (2009) Synthetic polymer scaffolds for tissue engineering. Chem Soc Rev 38(4):1139–1151
Porter JR, Ruckh TT, Popat KC (2009) Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog 25(6):1539–1560
Prabaharan M, Jayakumar R (2009) Chitosan-graft-β-cyclodextrin scaffolds with controlled drug release capability for tissue engineering applications. Int J Biol Macromol 44(4):320–325
Rahaman MN, Day DE, Bal BS, Fu Q, Jung SB, Bonewald LF, Tomsia AP (2011) Bioactive glass in tissue engineering. Acta Biomater 7(6):2355–2373
Raisz LG (1999) Physiology and pathophysiology of bone remodeling. Clin Chem 45(8):1353–1358
Ramchandani M, Robinson D (1998) In vitro and in vivo release of ciprofloxacin from PLGA 50: 50 implants. J Control Release 54(2):167–175
Raymond AK, Jaffe N (2009) Osteosarcoma multidisciplinary approach to the management from the pathologist’s perspective. In: Pediatric and adolescent osteosarcoma. Springer, New York, pp 63–84
Reichert JC, Hutmacher DW (2011) Bone tissue engineering. In: Tissue engineering. Springer, Berlin/Heidelberg, pp 431–456
Rezwan K, Chen Q, Blaker J, Boccaccini AR (2006) Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27(18):3413–3431
Ritter J, Bielack S (2010) Osteosarcoma. Annals Oncol 21(suppl_7):vii320–vii325
Rivron NC, Raiss CC, Liu J, Nandakumar A, Sticht C, Gretz N, Truckenmüller R, Rouwkema J, van Blitterswijk CA (2012) Sonic Hedgehog-activated engineered blood vessels enhance bone tissue formation. Proc Natl Acad Sci 109(12):4413–4418
Robling AG, Castillo AB, Turner CH (2006) Biomechanical and molecular regulation of bone remodeling. Annu Rev Biomed Eng 8:455–498
Saiz E, Zimmermann EA, Lee JS, Wegst UG, Tomsia AP (2013) Perspectives on the role of nanotechnology in bone tissue engineering. Dent Mater 29(1):103–115
Sarıgöl E, Bozdağ Pehlivan S, Ekizoğlu M, Sağıroğlu M, Çalış S (2017) Design and evaluation of gamma-sterilized vancomycin hydrochloride-loaded poly (ɛ-caprolactone) microspheres for the treatment of biofilm-based medical device-related osteomyelitis. Pharm Dev Technol 22(6):706–714
Sarıgöl E, Ekizoğlu M, Pehlivan SB, Bodur E, Sağıroğlu M, Çalış S (2018) A thermosensitive gel loaded with an enzyme and an antibiotic drug for the treatment of periprosthetic joint infection. J Drug Delivery Sci Technol 43:423–429
Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M (2006) Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 37(2):S105–S112
Sears NA, Seshadri DR, Dhavalikar PS, Cosgriff-Hernandez E (2016) A review of three-dimensional printing in tissue engineering. Tissue Eng Part B Rev 22(4):298–310
Shao H, Sun M, Zhang F, Liu A, He Y, Fu J, Yang X, Wang H, Gou Z (2018) Custom repair of mandibular bone defects with 3D printed bioceramic scaffolds. J Dent Res 97(1):68–76
Sidney LE, Heathman TR, Britchford ER, Abed A, Rahman CV, Buttery LD (2014) Investigation of localized delivery of diclofenac sodium from poly (D, L-lactic acid-co-glycolic acid)/poly (ethylene glycol) scaffolds using an in vitro osteoblast inflammation model. Tissue Eng A 21(1–2):362–373
Somayaji B, Jariwala U, Jayachandran P, Vidyalakshmi K, Dudhani RV (1998) Evaluation of antimicrobial efficacy and release pattern of tetracycline and metronidazole using a local delivery system. J Periodontol 69(4):409–413
Song Y-Y, Schmidt-Stein F, Bauer S, Schmuki P (2009) Amphiphilic TiO2 nanotube arrays: an actively controllable drug delivery system. J Am Chem Soc 131(12):4230–4232
Soundrapandian C, Sa B, Datta S (2009) Organic–inorganic composites for bone drug delivery. AAPS PharmSciTech 10(4):1158–1171
Stevens MM (2008) Biomaterials for bone tissue engineering. Mater Today 11(5):18–25
Sun M, Chen M, Wang M, Hansen J, Baatrup A, Dagnaes-Hansen F, Rölfing J, Jensen J, Lysdahl H, Li H (2016) In vivo drug release behavior and osseointegration of a doxorubicin-loaded tissue-engineered scaffold. RSC Adv 6(80):76237–76245
Suresh S, Saifuddin A (2007) Radiological appearances of appendicular osteosarcoma: a comprehensive pictorial review. Clin Radiol 62(4):314–323
Ta HT, Dass CR, Choong PF, Dunstan DE (2009) Osteosarcoma treatment: state of the art. Cancer Metastasis Rev 28(1–2):247–263
Taepaiboon P, Rungsardthong U, Supaphol P (2006) Drug-loaded electrospun mats of poly (vinyl alcohol) fibres and their release characteristics of four model drugs. Nanotechnology 17(9):2317–2329
Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27(2):302–345
Tarafder S, Bose S (2014) Polycaprolactone-coated 3D printed tricalcium phosphate scaffolds for bone tissue engineering: in vitro alendronate release behavior and local delivery effect on in vivo osteogenesis. ACS Appl Mater Interfaces 6(13):9955–9965
Tarafder S, Balla VK, Davies NM, Bandyopadhyay A, Bose S (2013) Microwave-sintered 3D printed tricalcium phosphate scaffolds for bone tissue engineering. J Tissue Eng Regen Med 7(8):631–641
Vivanco J, Slane J, Nay R, Simpson A, Ploeg H-L (2011) The effect of sintering temperature on the microstructure and mechanical properties of a bioceramic bone scaffold. J Mech Behav Biomed Mater 4(8):2150–2160
Vivanco J, Aiyangar A, Araneda A, Ploeg H-L (2012) Mechanical characterization of injection-molded macro porous bioceramic bone scaffolds. J Mech Behav Biomed Mater 9:137–152
Wang DA, Williams CG, Yang F, Elisseeff JH (2004) Enhancing the tissue-biomaterial Interface: tissue-initiated integration of biomaterials. Adv Funct Mater 14(12):1152–1159
Wang X, Hunter D, Xu J, Ding C (2015) Metabolic triggered inflammation in osteoarthritis. Osteoarthr Cartil 23(1):22–30
Wang X, Xu S, Zhou S, Xu W, Leary M, Choong P, Qian M, Brandt M, Xie YM (2016) Topological design and additive manufacturing of porous metals for bone scaffolds and orthopaedic implants: a review. Biomaterials 83:127–141
Wiesmann H, Meyer U, Plate U, Hohling H (2005) Aspects of collagen mineralization in hard tissue formation. Int Rev Cytol 242:121–156
Williams JM, Adewunmi A, Schek RM, Flanagan CL, Krebsbach PH, Feinberg SE, Hollister SJ, Das S (2005) Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 26(23):4817–4827
Woesz A, Rumpler M, Stampfl J, Varga F, Fratzl-Zelman N, Roschger P, Klaushofer K, Fratzl P (2005) Towards bone replacement materials from calcium phosphates via rapid prototyping and ceramic gelcasting. Mater Sci Eng C 25(2):181–186
Wolinsky JB, Colson YL, Grinstaff MW (2012) Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. J Control Release 159(1):14–26
Wolstenholme GEW, O’Connor M (2009) Bone structure and metabolism. Wiley, Chichester
Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM (2000) Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 276(2):461–465
Yang S, Leong K-F, Du Z, Chua C-K (2002) The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng 8(1):1–11
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sarigol-Calamak, E., Hascicek, C. (2018). Tissue Scaffolds As a Local Drug Delivery System for Bone Regeneration. In: Chun, H., Park, C., Kwon, I., Khang, G. (eds) Cutting-Edge Enabling Technologies for Regenerative Medicine. Advances in Experimental Medicine and Biology, vol 1078. Springer, Singapore. https://doi.org/10.1007/978-981-13-0950-2_25
Download citation
DOI: https://doi.org/10.1007/978-981-13-0950-2_25
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0949-6
Online ISBN: 978-981-13-0950-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)